NCT06022276 2023-09-01
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors
Tianjin Medical University Second Hospital
Phase NA Unknown
Tianjin Medical University Second Hospital
Tianjin Medical University Cancer Institute and Hospital
Biotech Pharmaceutical Co., Ltd.